771 related articles for article (PubMed ID: 17569746)
1. Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores.
McCann LJ; Garay SM; Ryan MM; Harris R; Riley P; Pilkington CA
Rheumatology (Oxford); 2007 Aug; 46(8):1363-6. PubMed ID: 17569746
[TBL] [Abstract][Full Text] [Related]
2. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies.
Huber AM; Feldman BM; Rennebohm RM; Hicks JE; Lindsley CB; Perez MD; Zemel LS; Wallace CA; Ballinger SH; Passo MH; Reed AM; Summers RM; White PH; Katona IM; Miller FW; Lachenbruch PA; Rider LG;
Arthritis Rheum; 2004 May; 50(5):1595-603. PubMed ID: 15146430
[TBL] [Abstract][Full Text] [Related]
3. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
Lovell DJ; Lindsley CB; Rennebohm RM; Ballinger SH; Bowyer SL; Giannini EH; Hicks JE; Levinson JE; Mier R; Pachman LM; Passo MH; Perez MD; Reed AM; Schikler KN; Smith M; Zemel LS; Rider LG
Arthritis Rheum; 1999 Oct; 42(10):2213-9. PubMed ID: 10524696
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.
Maillard SM; Jones R; Owens C; Pilkington C; Woo P; Wedderburn LR; Murray KJ
Rheumatology (Oxford); 2004 May; 43(5):603-8. PubMed ID: 14983103
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of penetration and aspiration on videofluoroscopy in normal individuals without dysphagia.
Allen JE; White CJ; Leonard RJ; Belafsky PC
Otolaryngol Head Neck Surg; 2010 Feb; 142(2):208-13. PubMed ID: 20115976
[TBL] [Abstract][Full Text] [Related]
6. Role of videofluorography swallow study in management of dysphagia in neurologically compromised patients.
Barbiera F; Condello S; De Palo A; Todaro D; Mandracchia C; De Cicco D
Radiol Med; 2006 Sep; 111(6):818-27. PubMed ID: 16896559
[TBL] [Abstract][Full Text] [Related]
7. Comparison between swallowing-related and limb muscle involvement in dermatomyositis patients.
Kim SJ; Han TR; Jeong SJ; Beom JW
Scand J Rheumatol; 2010 Aug; 39(4):336-40. PubMed ID: 20476862
[TBL] [Abstract][Full Text] [Related]
8. Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire.
Feldman BM; Ayling-Campos A; Luy L; Stevens D; Silverman ED; Laxer RM
J Rheumatol; 1995 Feb; 22(2):326-31. PubMed ID: 7738957
[TBL] [Abstract][Full Text] [Related]
9. Quantitative videofluoroscopic analysis of penetration-aspiration in post-stroke patients.
Bingjie L; Tong Z; Xinting S; Jianmin X; Guijun J
Neurol India; 2010; 58(1):42-7. PubMed ID: 20228462
[TBL] [Abstract][Full Text] [Related]
10. The 3-ounce (90-cc) water swallow challenge: a screening test for children with suspected oropharyngeal dysphagia.
Suiter DM; Leder SB; Karas DE
Otolaryngol Head Neck Surg; 2009 Feb; 140(2):187-90. PubMed ID: 19201286
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of bedside swallow evaluation versus videofluoroscopy to assess dysphagia in individuals with tetraplegia.
Shem KL; Castillo K; Wong SL; Chang J; Kao MC; Kolakowsky-Hayner SA
PM R; 2012 Apr; 4(4):283-9. PubMed ID: 22541374
[TBL] [Abstract][Full Text] [Related]
12. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.
Ruperto N; Ravelli A; Murray KJ; Lovell DJ; Andersson-Gare B; Feldman BM; Garay S; Kuis W; Machado C; Pachman L; Prieur AM; Rider LG; Silverman E; Tsitsami E; Woo P; Giannini EH; Martini A; ;
Rheumatology (Oxford); 2003 Dec; 42(12):1452-9. PubMed ID: 12832713
[TBL] [Abstract][Full Text] [Related]
13. Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: A case-control study.
Sanner H; Kirkhus E; Merckoll E; Tollisen A; Røisland M; Lie BA; Taraldsrud E; Gran JT; Flatø B
Arthritis Care Res (Hoboken); 2010 Aug; 62(8):1103-11. PubMed ID: 20506141
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study.
Apaz MT; Saad-Magalhães C; Pistorio A; Ravelli A; de Oliveira Sato J; Marcantoni MB; Meiorin S; Filocamo G; Pilkington C; Maillard S; Al-Mayouf S; Prahalad S; Fasth A; Joos R; Schikler K; Mozolova D; Landgraf JM; Martini A; Ruperto N;
Arthritis Rheum; 2009 Apr; 61(4):509-17. PubMed ID: 19333974
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
Huber AM; Hicks JE; Lachenbruch PA; Perez MD; Zemel LS; Rennebohm RM; Wallace CA; Lindsley CB; Passo MH; Ballinger SH; Bowyer SL; Reed AM; White PH; Katona IM; Miller FW; Rider LG; Feldman BM;
J Rheumatol; 2001 May; 28(5):1106-11. PubMed ID: 11361197
[TBL] [Abstract][Full Text] [Related]
16. Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy.
Naim MY; Reed AM
J Rheumatol; 2006 Jul; 33(7):1392-4. PubMed ID: 16821273
[TBL] [Abstract][Full Text] [Related]
17. Swallowing difficulties in Duchenne muscular dystrophy: indications for feeding assessment and outcome of videofluroscopic swallow studies.
Aloysius A; Born P; Kinali M; Davis T; Pane M; Mercuri E
Eur J Paediatr Neurol; 2008 May; 12(3):239-45. PubMed ID: 18055233
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use.
Santiago RA; Silva CA; Caparbo VF; Sallum AM; Pereira RM
Scand J Rheumatol; 2008; 37(1):40-7. PubMed ID: 18189194
[TBL] [Abstract][Full Text] [Related]
19. Duration of illness is an important variable for untreated children with juvenile dermatomyositis.
Pachman LM; Abbott K; Sinacore JM; Amoruso L; Dyer A; Lipton R; Ilowite N; Hom C; Cawkwell G; White A; Rivas-Chacon R; Kimura Y; Ray L; Ramsey-Goldman R
J Pediatr; 2006 Feb; 148(2):247-53. PubMed ID: 16492437
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis.
Riley P; McCann LJ; Maillard SM; Woo P; Murray KJ; Pilkington CA
Rheumatology (Oxford); 2008 Jun; 47(6):877-80. PubMed ID: 18403404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
